Farahani, Pendar, et al. “CLINICAL DATA GAP BETWEEN PHASE III CLINICAL TRIALS (PRE-MARKETING) AND PHASE IV (POST-MARKETING) STUDIES: EVALUATION OF ETANERCEPT IN RHEUMATOID ARTHRITIS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 12, no. 3, Dec. 2018, https://mail.jptcp.com/index.php/jptcp/article/view/99.